BusinessCann
BusinessCann · page 15
- CBD Market
2022 Will See The Race To The Bottom Replaced By A Healthy Focus On Profitable Business Models
Stenocare CEO Thomas Skovlund Schnegelsberg reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities and challenges for the European cannabis industry in 2022?
- CBD Market
Love Hemp Launches Tie Up with Deliveroo in London to Deliver its Range of Products
Love Hemp Group, the brand-led consumer goods company focussed on CBD health and wellness solutions, is pleased to announce it has launched, on a trial basis, with Deliveroo, the on-demand delivery service.
- CBD Market
Germany Needs Workable Adult-Use Legislation Capable Of Drying-Up The Illicit Market.
Leading German Cannabis Lawyer Kai-Friedrich Niermann reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities and challenges for the European cannabis industry in 2022 K-FN: The cannabis industry in Europe in its various sectors – medical, commercial hemp and CBD – has…
- Uncategorized
Deutschland braucht ein tragfähiges Erwachsenengesetz, um den illegalen Markt auszutrocknen.
Kai-Friedrich Niermann, einer der führenden deutschen Cannabis-Anwälte, blickt auf das Jahr 2021 zurück und gibt einen Ausblick auf die Herausforderungen und Chancen, die im Jahr 2022 vor ihm liegen BC: Was sind die wichtigsten Chancen und Herausforderungen für die europäische Cannabisindustrie im Jahr 2022?
- Press releases
Global CBD and Wellness Brand Elixinol Set to be ‘Powered by British Cannabis’ in the UK
CBD Health Foods Ltd, trading as BRITISH CANNABIS™, is pleased to announce that it has entered into an exclusive Trademark & Know-How License Agreement (Agreement) with Elixinol Wellness Limited (Elixinol) (ASX:EXL; OTCQB:ELLXF), the wholly owned subsidiary of Elixinol Wellness (Corporate Services) Pty Ltd, to sell CBD products across the UK.
- CBD Market
CBD Consumers Want Trusted Brands And High-Quality Products Backed By Regulators and Retailers
In a Q&A with BusinessCann Eoin Keenan, CEO & Co-Founder, Goodrays, says after seven years working in the industry he expects 2022 to be a break-through year BC: What developments should we expect to see in the European cannabis industry in 2022?
- Opinion
‘The European Cannabis Industry Has Passed The Point Of No Return’
In a Q&A with BusinessCann looking ahead to 2022 Lino Cereghetti, Chief Operating Officer at Swiss company Pure Holding says it is only a matter of time before other countries follow Germany with progressive regulations BC: What developments should we expect to see in the European cannabis industry in 2022?
- Press releases
Materia Malta Commences First Sales of Medical Cannabis in Europe
Kanabo Group Plc (LSE:KNB), a medical cannabis and R&D Company that focuses on the distribution of cannabis-derived products for medical patients and wellness CBD consumers, notes that Materia’s wholly-owned subsidiary Materia Malta Operating Ltd. (“Materia Malta“) has commenced sales in Europe of the first medical cannabis flower produced at its EU GMP certified manufacturing site.
- Press releases
Kanabo’s CBD Based ‘Smoking Cessation” Formula Moves Closer to Full Patent Approval
Kanabo Group Plc (LSE:KNB), a medical cannabis and R&D Company that focuses on the distribution of cannabis-derived products for medical patients and wellness CBD consumers, is pleased to announce that its unique CBD and nicotine formula has advanced from Patent Cooperation Treaty (PCT) phase to National Phase in the US, UK, and EU countries – the…
- CBD Market
Europe’s Decision to Raise Permitted THC Levels in Hemp Crops Is ‘A Victory For Science’
The recent increase in hemp crop THC levels represents not only a win for the European hemp sector, but also a step forward in the direction of more science-based policies, says Lorenza Romanese.
- CBD Market
Dragonfly Biosciences UK Expects to Commence Trading On The Australian Securities Exchange Early January 2022
British Company, Dragonfly Biosciences UK, the makers of Dragonfly CBD, Europe’s largest and leading, award winning seed to shelf range of CBD oils and skincare products, is excited to announce that its prospectus has been approved by the Australian Securities and Investments Commission.
